DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase

          DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase Mithra on-track for completion of Phase 3 study for DONESTA® to...

Related Keywords

Germany ,Belgium ,United States ,Belgian ,Graham Dixon ,Alex Sokolowski ,Mithra Pharmaceuticals ,Ir Communications ,Women Health ,Linkedin ,Facebook ,Mithra Pharmaceuticals Sa Euronext ,European Union ,Euronext Brussels ,Clinical Study Report ,Female Sexual Arousal Disorder ,Chief Scientific Officer ,Markets ,